650 related articles for article (PubMed ID: 31218726)
1. Epigenetic polypharmacology: A new frontier for epi-drug discovery.
Tomaselli D; Lucidi A; Rotili D; Mai A
Med Res Rev; 2020 Jan; 40(1):190-244. PubMed ID: 31218726
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
de Lera AR; Ganesan A
Clin Epigenetics; 2016; 8():105. PubMed ID: 27752293
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.
Ranganna K; Selvam C; Shivachar A; Yousefipour Z
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147762
[TBL] [Abstract][Full Text] [Related]
4. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W; Bai Y; Wang Y; Xiao W
Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer.
Stazi G; Fioravanti R; Mai A; Mattevi A; Valente S
Curr Opin Chem Biol; 2019 Jun; 50():89-100. PubMed ID: 30986654
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacology: challenges and opportunities in drug discovery.
Anighoro A; Bajorath J; Rastelli G
J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacology of Approved Anticancer Drugs.
Amelio I; Lisitsa A; Knight RA; Melino G; Antonov AV
Curr Drug Targets; 2017; 18(5):534-543. PubMed ID: 26926468
[TBL] [Abstract][Full Text] [Related]
9. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
Ma X; Lv X; Zhang J
Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
[TBL] [Abstract][Full Text] [Related]
10. Computational polypharmacology: a new paradigm for drug discovery.
Chaudhari R; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
[TBL] [Abstract][Full Text] [Related]
11. An
Prieto-Martínez FD; Fernández-de Gortari E; Medina-Franco JL; Espinoza-Fonseca LM
Artif Intell Life Sci; 2021 Dec; 1():. PubMed ID: 35475037
[TBL] [Abstract][Full Text] [Related]
12. Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.
Stelitano G; Sammartino JC; Chiarelli LR
Molecules; 2020 Mar; 25(5):. PubMed ID: 32182964
[TBL] [Abstract][Full Text] [Related]
13. Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development.
Stefan SM; Rafehi M
Drug Dev Res; 2024 Feb; 85(1):e22125. PubMed ID: 37920929
[TBL] [Abstract][Full Text] [Related]
14. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Ravikumar B; Aittokallio T
Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
[TBL] [Abstract][Full Text] [Related]
15. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
Singh D; Khan MA; Siddique HR
Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
[TBL] [Abstract][Full Text] [Related]
16. An up-to-date overview of computational polypharmacology in modern drug discovery.
Chaudhari R; Fong LW; Tan Z; Huang B; Zhang S
Expert Opin Drug Discov; 2020 Sep; 15(9):1025-1044. PubMed ID: 32452701
[TBL] [Abstract][Full Text] [Related]
17. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
18. AI for targeted polypharmacology: The next frontier in drug discovery.
Cichońska A; Ravikumar B; Rahman R
Curr Opin Struct Biol; 2024 Feb; 84():102771. PubMed ID: 38215530
[TBL] [Abstract][Full Text] [Related]
19. Web-Based Tools for Polypharmacology Prediction.
Awale M; Reymond JL
Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
[TBL] [Abstract][Full Text] [Related]
20. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
